Overactive Bladder
Health utility value of overactive bladder in Japanese older adults.
February 9, 2025
Up-and-coming pharmacotherapeutic options for treating patients with refractory overactive bladder.
February 9, 2025
Can Baseline Urodynamic Findings Predict the Outcomes and Complications of Intravesical Injections of Onabotulinum Toxin A for Overactive Bladder?
February 9, 2025
Exploring the Association Between Overactive Bladder (OAB) and Cognitive decline: mediation by depression in elderly adults, a NHANES weighted analysis.
January 31, 2025
Efficacy of 100-U Onabotulinumtoxin A Treatment in Female Idiopathic Overactive Bladder-A Prospective Follow-Up Study.
January 31, 2025
Increased Afferent Nerve Firing Is Correlated With the Detection of Bladder Wall Micromotion in a Perfused Ex-Vivo Porcine Model.
January 26, 2025
Efficacy of Combined Therapy With Silodosin and Solifenacin in Females With Overactive Bladder.
January 26, 2025
Onabotulinum Toxin A-Led Urinary Tract Infections-Should we Safeguard? A Randomized Controlled Trial.
January 26, 2025
Multi-center, prospective, non-interventional, observational study on the efficacy and safety of Mirabek® in adult patients with overactive bladder.
January 17, 2025
Systematic review and meta-analysis on the association of metabolic syndrome in women with overactive bladder.
January 10, 2025
Trends in Medicare Coverage of Overactive Bladder Medications in the United States.
January 10, 2025
Complicated Overactive Bladder Management.
January 10, 2025
The Association Between Anthropometric Indices and Overactive Bladder (OAB): A Cross-Sectional Study From the NHANES 2005-2018.
January 3, 2025